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Abstract
Introduction: Haemodialysis has direct and indirect effects on skin
and muscle microcirculatory regulation that are severe enough to
worsen tolerance to physical exercise and muscle asthenia in
patients undergoing dialysis, thus compromising patients’ quality of
life and increasing the risk of mortality. In diabetes these
circumstances are further complicated, leading to an approximately
sixfold increase in the incidence of critical limb ischaemia and
amputation. Our aim in this study was to investigate in vivo
whether haemodialysis induces major changes in skeletal muscle
oxygenation and blood flow, microvascular compliance and tissue
metabolic rate in patients with and without diabetes.
Methods:  The study included 20 consecutive patients with and
without diabetes undergoing haemodialysis at Sant Andrea
University Hospital, Rome from March to April 2007. Near-infrared
spectroscopy (NIRS) quantitative measurements of tissue haemo-
globin concentrations in oxygenated [HbO2] and deoxygenated
forms [HHb] were obtained in the calf once hourly for 4 hours
during dialysis. Consecutive venous occlusions allowed one to
obtain muscular blood flow (mBF), microvascular compliance and
muscle oxygen consumption (mVO2). The tissue oxygen saturation
(StO2) and content (CtO2) as well as the microvascular bed volume
were derived from the haemoglobin concentration. Nonparametric
tests were used to compare data within each group and among the
groups and with a group of 22 matched healthy controls.
Results: The total haemoglobin concentration and [HHb] increased
significantly during dialysis in patients without and with diabetes.
Only in patients with diabetes, dialysis involved a [HbO2], CtO2 and
mVO2 increase but left StO2 unchanged. Multiple regression
analysis disclosed a significant direct correlation of StO2 with HbO2
and an inverse correlation with mVO2. Dialysis increased mBF only
in diabetic patients. Microvascular compliance decreased rapidly
and significantly during the first hour of dialysis in both groups.
Conclusions:  Our NIRS findings suggest that haemodialysis in
subjects at rest brings about major changes in skeletal muscle
oxygenation, blood flow, microvascular compliance and tissue
metabolic rate. These changes differ in patients with and without
diabetes. In all patients haemodialysis induces changes in tissue
haemoglobin concentrations and microvascular compliance,
whereas in patients with diabetes it alters tissue blood flow, tissue
oxygenation (CtO2, [HbO2]) and the metabolic rate (mVO2). In
these patients the mVO2 is correlated to the blood supply. The
effects of haemodialysis on cell damage remain to be clarified. The
absence of StO2 changes is probably linked to an opposite
[HbO2] and mVO2 pattern.
Introduction
Knowing how haemodialysis influences skeletal muscle
circulation is of clinical importance given the growing
evidence suggesting that the microcirculation has a key role
in worsening tolerance to physical exercise in patients under-
going dialysis [1,2].
Muscle asthenia is among the complications of dialysis that
can compromise patient quality of life [3]. The decreased
aerobic capacity that ensues when muscle dysfunction
impairs patients’ ability to carry out the normal activities of
everyday life is associated with an increased risk of mortality
[4], suggesting that physical training could lengthen the life
expectancy of patients with chronic renal failure [2].
Despite numerous studies investigating the various features
of muscle dysfunction during dialysis, none have yet identified
a single, proven causative factor.
The possibility that muscle symptoms depend on altered
microcirculatory oxygen transport and functionality receives
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support from several observations, including reduced
capillary density in muscle tissue [2,5], diminished vasodilator
response to post-ischaemia reperfusion [6,7] and impaired
endothelium-dependent vasodilation [8,9]. The most
commonly used non-invasive technique that can also be used
clinically at the bedside for directly assessing microvascular
dysfunction and skeletal muscle oxygenation is near-infrared
spectroscopy (NIRS) [10].
Some evidence nevertheless suggests that dialysis-induced
changes in muscle exercise performance depend exclusively
on reduced mitochondrial oxidative capacity without a defect
in oxygen transport [1].
In diabetes, the circumstances are further complicated by the
typical diabetic changes [11] that frequently lead to end-
stage renal disease. In patients with diabetes, haemodialysis
can bring about a sixfold increase in the incidence of critical
limb ischaemia and amputation. Major lower-extremity ampu-
tation is especially likely in the first 12 months after patients
start renal replacement therapy [12,13].
Although previous studies have investigated changes in
systemic haemodynamics [14] and forearm blood flow [15]
during hemodialysis, few and only indirect studies have
assessed  in vivo dialysis-induced changes in the muscle
tissue. This information might help to explain how dialysis
acts on muscle tissue and why muscular performance
worsens in patients undergoing dialysis.
Our primary aim in the present in vivo study in humans was to
determine whether haemodialysis brings about major
changes in skeletal muscle oxygenation and blood flow, in
microvascular compliance (the ability of small blood vessels
in muscle tissue to dilate) and in the tissue metabolic rate
measured at rest. We also wanted to investigate possible
physiological interactions between these four variables during
haemodialysis, and to identify differences in the patterns of
change in these tissue variables during haemodialysis in
patients with and without diabetes.
Our secondary aim was to detect differences in baseline
variables in patients with and without diabetes and in healthy
subjects. We non-invasively assessed the calf-muscle haemo-
globin (Hb) concentration (total and fractional Hb concen-
tration, oxygenated tissue haemoglobin concentration
[HbO2]), tissue oxygen saturation (StO2) and tissue oxygen
content (CtO2), blood flow and muscle oxygen consumption
(mVO2) simultaneously by NIRS in the two groups (patients
with diabetes and patients without diabetes) before
haemodialysis and hourly for 4 hours.
Materials and methods
Selection of subjects
The study was conducted at Sant Andrea Hospital, Rome
from March to April 2007. The study protocol was approved
by the hospital Anesthesia and Intensive Care Medicine
Department and Dialysis Unit Institutional Review Board, and
informed consent was obtained from each participant. We
enrolled 20 consecutive patients from the Dialysis Unit,
selecting those with a 5-year history of end-stage renal
disease who had never changed their treatment modality,
who had received similar dialytic treatment (see Haemo-
dialysis management), who had required no hospitalizations
in the month before the study and who had no signs of
infections or other diseases. All patients had undergone
regular cardiogical follow-up with 6-monthly electrocardio-
grams and echocardiograms when necessary.
Patients younger than 18 years and older than 80 years of
age were excluded. We also excluded patients who had a
history of autonomic nervous system dysfunction or who
experienced hypotensive episodes during dialysis. Further
exclusion criteria were patients with lower-limb changes likely
to interfere with NIRS readings (marked oedema, abundant
subcutaneous fat, varicose veins, diabetic ulcers, and
traumatic or surgical scars), patients with cardiac insuffi-
ciency (New York Health Association class III or IV) or
moderate or severe chronic obstructive pulmonary disease, or
both, and patients who were unable to tolerate the venous
occlusion procedures foreseen in the study protocol.
Routine monitoring included the intravascular Hb content,
pulse oximetry, non-invasive blood pressure measurement,
body weight (kg), and gastrocnemius muscle skinfold thick-
ness. The blood pressure and heart rate were recorded
during each dialysis session every 30 minutes.
Patients were sequentially enrolled and assigned to one of
two groups according to the presence or absence of insulin-
treated diabetes: patients with diabetes (n = 10) and patients
without diabetes (n = 10). As a control group to compare
baseline values, we enrolled 22 healthy subjects who had
taken part in an earlier study.
Haemodialysis management
All patients received erythropoietin in intravenous boluses of
2,000 to 15,000 units three times a week as well as oral or
intravenous iron supplementation for at least 2 months before
the study. All patients underwent haemodialysis three times a
week according to a standardized technique. The weekly
measure of dialysis adequacy – calculated as the product of
urea clearance and dialysis time divided by the body water
content (Kt/V) – for the preceding month was >1.2. All
patients received bicarbonate-based haemodialysis with
ultrafiltration using a distal arteriovenous shunt. The dialysate
rate was 500 ml/minute and blood flow was maintained at
300 ml/minute. All patients were dialyzed with the same
machine (Integra; Hospal, Zaventem Belgium). Polysulphone
dialysers were used in all patients with an effective membrane
area of 1.6 to 1.8 m2 F7 HPS and F8 HPS low flux (Fresenius
Medical Care, Bad Homburg, Germany). The dialysateconsisted of potassium 2.0 mmol/l, calcium 1.5 mmol/l,
bicarbonate 32 mmol/l, magnesium 0.5 mmol/l, acetate
3.0 mmol/l, and glucose 1.0 g/l. The dialysate temperature
was kept at 36°C to maintain haemodynamic stability [16].
Near-infrared spectroscopy data collection
Before haemodialysis began, an NIRS probe (NIMO-4 tissue
probe; Nirox srl, Brescia, Italy) was placed and secured with
an elastic band along the lateral side of the calf (lateral
gastrocnemius muscle), taking care not to apply it over
possible haematomas or along the course of visible veins. To
avoid hampering venous return the leg was kept with the
thigh on a level with the heart and the foot raised by about
10 cm. Two pneumatic cuffs were attached around the thigh
and the ankle, and were connected to an automatic inflation
system (Hokanson E20 Rapid Cuff Inflator and AG101 Cuff
Inflator Air Source, PMS Instruments Ltd, Maidenhead,
Berkshire, UK) capable of reaching a predefined pressure in
less than 0.5 seconds. To avoid the possible interference of
ambient light on NIRS measurements, the whole leg was
wrapped in a black cloth. Just before applying the probe, the
calf skinfold thickness was measured using a skinfold caliper
(Gima SpA, Gessate, Milan, Italy).
One set of NIRS measurements was recorded once hourly for
4 hours during dialysis. The first measurement set was defined
as predialysis, whereas the ensuing sets were measured at
the beginning of the second hour, the third hour and the fourth
hour of dialysis. Three consecutive pneumatic cuff inflation
pressures at 30 mmHg, 40 mmHg, and 50 mmHg – or, in
patients with diastolic pressures <50 mmHg, a maximum value
equal to the diastolic pressure minus 10 mmHg – were
maintained for about 50 seconds (venous occlusion) with
10 seconds between compressions (Figure 1). The baseline
recording was continued during the interval between
compressions until the next hour when subjects underwent
venous compressions again. All data recorded were stored on
a laptop computer for offline analysis.
Near-infrared spectrometer
The Hb concentrations were quantified with a commercially
available continuous-wave tissue oxymeter (NIMO; Nirox srl,
Brescia, Italy), as detailed elsewhere [17,18]. The oximeter
measures the absolute tissue [HbO2] and deoxygenated tissue
haemoglobin concentration [HHb] from the light absorption
spectrum at a wavelength of 980 nm that corresponds to
maximal optical absorption of water within the tissue. To
account for the possible influence of the subcutaneous fat
layer on NIRS [19], we also applied a real-time correction
using an algorithm included in the software program version
2.0 supplied with the spectrometer. The correlation
coefficients used for the algorithm were obtained by applying
a two-layered analytical model [20] using absorption and
scattering coefficients of the fat layer for wavelengths of
interest obtained from the literature [21]. The measurement of
the subcutaneous two-layered fat by skinfold anthropometry
is a widely used and valid technique to estimate the muscular
mass of subjects with chronic renal disease [22].
Offline data processing
All recorded tracks were visually inspected: a venous
occlusion was determined as satisfactory for further analysis
if the baseline track remained steady before occlusion, then
oxyhaemoglobin and deoxyhaemoglobin rose during the
occlusion, returning to a similar baseline level after the
occlusion was released. Data were analysed offline with the
software program supplied with the NIMO oximeter (Nimo
Data Analysis v2.0; Nirox srl).
The variables measured by NIRS are presented in Table 1.
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Figure 1
Total haemoglobin concentration variation during consecutive venous occlusion. Representative trace of total haemoglobin concentration [HbT]
changes during four consecutive venous occlusions at different pneumatic cuff inflation pressures.The spectrophotometer directly measured [HbO2] and the
haemoglobin concentration; StO2 was obtained automatically
from the ratio of [HbO2] to the total haemoglobin concen-
tration [HbT]. Blood flow was measured in two ways.
Because oxygen delivery depends closely on the Hb flow and
because capillary and arteriolar haematocrit are significantly
lower than systemic haematocrit [23], we measured the linear
increase in [HbT] within the first 20 seconds of a 40 mmHg
venous occlusion, expressed in micromoles per 100 ml tissue
per minute [24,25] – muscular haemoglobin flow (mHF). We
also calculated muscular blood flow (mBF), expressed in
millilitres of blood/100 ml per minute, converting the [HbT]
changes during venous occlusion to millilitres of blood per
100 ml tissue per minute using the Hb content obtained from
blood samples drawn at each hour.
Microvascular compliance was calculated as the [HbT]
changes at different venous occlusion pressures and
expressed as millilitres of blood increase in 100 ml tissue per
change in pressure (mmHg), converting the [HbT] to millilitres
using the Hb blood content as previously described [10]. The
[HbT] values were collected approximately 30 to 40 seconds
after each cuff inflation at the plateau phase when superficial,
deep, and other small vessels were assumed to be fully
distended. Compliance curves were obtained by plotting the
relationship between cuff pressure and [HbT]. These values
were expressed in millilitres of blood per mmHg taking into
account the vascular Hb content. The CtO2 (expressed in
millilitres of oxygen per 100 ml tissue) was calculated
considering the fractional StO2, [HbT] (expressed in grams),
and the millilitres of oxygen bound by 1 g Hb (1.36 ml O2/g
HbT) [10].
The mVO2 was measured during venous occlusion as the
initial linear increase in Hb concentration, after subtracting
the Hb concentration increase from arterial blood [24].
The data obtained were compared with those for the 22
matched healthy control subjects. Because the spectroscopy
measurements cannot distinguish whether the dialysis-induced
variations of tissue Hb concentration are related to the
intravascular increase of Hb concentration or to the increase of
the vascular bed, a percentage corresponding to the rate of the
hourly haematocrit changes has been substracted from the
hourly changes of tissue Hb concentration. This correction was
aimed to better show the importance of tissue [HbT] and its
derived variables (CtO2 and microvascular compliance),
changes related to vascular bed variations. The corrected data
obtained are reported in Table 2 and the statistical significance
is given in the Results section.
Statistical analysis
The results are expressed as the mean ± standard deviation.
The data were analysed with SPSS version 13.0 and Med
Calc Version 9.4.2.0 for Windows. Nonparametric tests were
used to compare data – the Friedman test and the Wilcoxon
test were used to compare data within each group, and the
Mann–Whitney U test was used to compare data among the
two groups and healthy controls. Spearman’s rank correlation
coefficient with a discriminant P <0.05 was used to identify
significant correlations between the variables measured
during dialysis.
Results
All 20 patients enrolled completed the study. All of these
patients tolerated NIRS measurements and manoeuvres for
vascular occlusion. The percentage of tracks discarded
because of their unreliability was 10%. Patient ages ranged
from 44 to 77 years. No differences were found between the
groups of subjects for age, thickness of subcutaneous fat,
vascular Hb content, and diastolic and systolic arterial
pressures. Conversely, the body weight differed between the
patients with diabetes and the other subjects (Table 3). Mean
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Table 1
Variables measured by near-infrared spectroscopy
Abbreviation Full name Units Type of measurement
[HbO2] Oxygenated haemoglobin concentration μmol/l Direct
[HHb] Deoxygenated haemoglobin concentration μmol/l Direct
[HbT] Total haemoglobin concentration μmol/l Calculated
StO2 Tissue oxygen saturation % Calculated
CtO2 Tissue oxygen content ml O2/100 ml Calculated
Compliance Microvascular compliance ml/mmHg/100 ml Calculated
mHF Muscular haemoglobin flow μmol/min/100 ml Calculated
mBF Muscular blood flow ml/min/100 ml Calculated
mVO2 Muscle oxygen consumption ml/min/100 ml Calculatedoverall weight loss was similar in the two groups and
diminished significantly by hour during dialysis (Table 4). Of
the 20 patients studied, 12 were anuric and eight had a low
glomerular filtration rate (1 to 9 ml/minute). Of the 10 non-
diabetic patients, three were normotensive and were not
receiving vasoactive drugs.
Cardiovascular function
All of the patients studied showed good haemodynamic stability
during dialysis, and no hypotensive episodes developed.
Total haemoglobin concentration
Predialysis [HbT] values in the patients studied almost
matched those in healthy subjects (Table 4). In the
nondiabetic patients as well as in the diabetic patients, [HbT]
increased significantly from baseline during dialysis
(Friedman test, P = 0.002 and P = 0.001). No significant
difference was found between groups.
At all timepoints, these increases remained statistically
unchanged when we corrected our subjects’ [HbT] values for
vascular Hb concentrations during dialysis (Table 2) –
suggesting that dialysis-induced fluid removal has no
influence on the [HbT] increase.
Deoxygenated tissue haemoglobin concentration
Predialysis [HHb] values in the patients studied also matched
those in healthy control subjects (Table 4). During dialysis,
[HHb] increased in both groups of patients (Friedman test,
P = 0.001). No differences were found between groups.
Oxygenated haemoglobin concentration
Predialysis [HbO2] values were approximately 36% lower in
patients with and without diabetes than in healthy subjects
(Table 4). In patients with diabetes, [HbO2] increased during
dialysis (Friedman test, P = 0.017); conversely, in patients
without diabetes, dialysis left [HbO2] values unchanged.
Muscular blood flow
In patients without diabetes, the mHF and mBF remained
unchanged during dialysis (Table 4) – whereas in those
patients with diabetes, the mHF and mBF increased only after
2 hours of dialysis. After dialysis for 2 hours, these variables
remained statistically unchanged.
Microvascular compliance
Predialysis microvascular compliance values were similar in
patients without diabetes and in healthy subjects, whereas
they were higher in diabetic patients (Table 4). In both groups
of patients studied, compliance decreased rapidly and signifi-
cantly during the first hour of dialysis, with a more
pronounced decrease in patients with diabetes (Friedman
test,  P = 0.003). Thereafter, in both groups of patients
compliance diminished further during the whole dialysis.
When we corrected data for vascular Hb concentration
changes, the differences in compliance remained statistically
unchanged (Table 2).
Tissue oxygen content
Predialysis CtO2 values were 38% and 34% lower in
patients without and with diabetes than in healthy control
subjects (Table 4). In patients without diabetes, the CtO2
remained statistically unchanged during dialysis – whereas
the CtO2 increased in patients with diabetes (Friedman test,
P = 0.01), approaching values similar to those measured in
healthy subjects. The same pattern was observed for the
CtO2 values corrected by the vascular Hb changes
(Table 2).
Tissue oxygen saturation
Predialysis StO2 values were similar in both groups of
patients and in healthy subjects. During haemodialysis, StO2
values remained unchanged. No significant differences were
found between the two groups.
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Table 2
Data corrected for possible variations in total haemoglobin concentration related to dialysis-induced fluid removal
Patients without diabetes (n = 10) Patients with diabetes (n = 10)
Variable T0 T1 T2 T3 T0 T1 T2 T3
Total haemoglobin  46.62a ±  56.33 ±  56.44 ±  56.25 ±  45.17a ±  58.33 ±  59.61 ±  66.53 ± 
concentration (μM/l) 18.44 17.05 17.38 17.69 17.43 21.40 22.75 23.51
Tissue oxygen content  0.18 ±  0.23 ±  0.20 ±  0.21 ±  0.20a ± 0.24  ±  0.26c ± 0.32  ± 
(ml O2/100 ml) 0.10 0.09 0.13 0.12 0.10 0.13 0.14 0.20
Microvascular compliance  0.153a ± 0.049b ±  0.010 ±  0.004 ±  0.203a ±  0.039 ±  0.016 ±  0.013 ± 
(μM/mmHg) 0.109 0.035 0.007 0.001 0.150 0.058 0.017 0.010
To take into account possible total haemoglobin concentration variations related to dialysis-induced fluid removal, the near-infrared spectroscopy
total haemoglobin concentration values and related variables (tissue oxygen content, and compliance) were corrected for vascular haemoglobin
changes during dialysis. T0, predialysis. The statistical analysis was performed with the Wilcoxon test, considering P <0.05 significant: aP <0.05
vs. beginning of the second hour (T1), beginning of the third hour (T2), beginning of the fourth hour (T3); bP <0.05 vs. T2, T3; cP <0.05 vs. T3.Muscle oxygen consumption
Predialysis mVO2 values were similar in the two groups of
patients and in healthy subjects. The mVO2 remained un-
changed in patients without diabetes during dialysis, whereas
in those patients with diabetes it increased by 148.3%
between predialysis and the beginning of the third hour and
by 100% between predialysis and the beginning of the fourth
hour (Friedman test, P = 0.002) (Table 4).
Oxygen supply/consumption relationship
In patients without diabetes, the variables correlating inversely
with mVO2 were StO2 and compliance (Spearman’s coef-
ficient = –0.58, P = 0.001, and –0.42, P = 0.025), whereas a
direct correlation was found between mVO2 and [HHb]
(Spearman’s coefficient = –0.54, P = 0.003). In patients with
diabetes, the only variables that correlated with mVO2 were
mHF and mBF (Spearman’s coefficient = 0.53, P = 0.006,
and 0.51, P = 0.004).
Discussion
Our results in the present in vivo study using NIRS to
investigate changes in skeletal muscle oxygenation and blood
flow, microvascular compliance, and mVO2 during haemo-
dialysis provide two major findings. The first finding is that
although haemodialysis left StO2 unchanged in both groups, it
strongly influenced Hb tissue concentrations and micro-
vascular compliance. Haemodialysis invariably caused greater
changes in patients with diabetes than in those without. A
second new finding in patients with diabetes was that, as well
as changing tissue haemoglobin concentration and micro-
vascular compliance, haemodialysis altered tissue blood flow
(mHF and mBF), tissue oxygenation (CtO2) and the metabolic
rate (mVO2). A secondary finding was that at baseline (before
haemodialysis) NIRS disclosed no differences in the
measured tissue variables in patients with and without
diabetes, whereas in patients with diabetes the baseline
values of microvascular compliance were higher than those in
the healthy control group (Table 4). These findings may help to
explain how haemodialysis influences muscular performance.
Skeletal muscle oxygenation
Our findings in the present study dictate two conclusions.
First – at least in the patients we studied, who had no signs
of cardiac or respiratory failure – dialysis leaves skeletal
muscle oxygenation unchanged. Second, instead of worsen-
ing the CtO2 further, dialysis increases the oxygen content in
diabetic persons and does so by increasing [HbO2] and
muscular tissue blood flow. Third, CtO2 increases during
dialysis, probably because dialysis reduces factors hindering
oxygen availability – in particular, the tissue water content.
Our NIRS findings showing that haemodialysis leaves skeletal
muscle oxygenation unchanged argue against previous
studies reporting reduced oxygenation during haemodialysis
[26,27].
Oxygenation during dialysis has been previously assessed in
various ways and in various tissues. The data obtained in
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Table 3
Anthropometric data, systemic vascular variables and causes of renal diseases
Healthy subjects  Patients without diabetes  Patients with diabetes 
Anthropometric data (n = 22) (n = 10) (n = 10) P value
Age (years) 56.8 ± 9.3 57.8 ± 11.5 60.1 ± 10.1 ns
Gender (male/female) 17/5 7/3 6/4 ns
Height (cm) 169.7 ± 8.1 169.7 ± 6.2 165.6 ± 1.7 ns
Subcutaneous fat layer (mm) 7.0 ± 2.3 6.5 ± 1.6 7.6 ± 1.0 ns
Baseline weight (kg) 77.3 ± 13.4 74.9 ± 18.8 93.8 ± 24.1* 0.048
Systemic vascular variables
Haemoglobin vascular (g/dl) 13.9 ± 0.9 12.3 ± 1.81 11.9 ± 1.9 ns
Systolic arterial pressure (mmHg) 136.6 ± 15.4 148.8 ± 21.5 160.1 ± 15.7 ns
Diastolic arterial pressure (mmHg) 85.34 ± 10.3 75.5 ± 17.8 84.3 ± 14.3 ns
Renal diseases
Diabetic nephropathy – – 10
Lupus nephritis – 1 –
Polycystic kidney disease – 2 –
Nephroangiosclerosis – 7 –
Mann–Whitney U-test. ns, not significant. *P = 0.048, patients with diabetes vs. patients without diabetes and healthy subjects.humans with transcutaneous partial pressure of oxygen
monitoring [27] show that oxygenation falls dramatically
during dialysis and remains low for at least 4 hours thereafter.
Previous studies also reported a 5 to 15% fall in the partial
pressure of oxygen in arterial blood within about 30 to
60 minutes after dialysis began that persisted throughout the
session [28]. The measurements of the oxygen tension could
be influenced by the acetate in the dialysis fluid, or by the
patients’ cardiopulmonary status [29], or by both. Although to
avoid arterial cannulation in patients attending the daycare
clinic we did not obtain serial measurements of the partial
pressure of oxygen in arterial blood, neither of these factors
influenced our results because our patients were dialyzed
with bicarbonate fluid and we excluded patients who had
signs of cardiac or respiratory failure. Furthermore, the
discrepancy between the oxygen tension measurements and
the Hb oxygenation rate measured by NIRS can be fully
explained considering that these variables reflect different
types of oxygenation differently affected by fluid removal.
The absence of differences between the studied variables in
the two groups of patients could depend on the small study
sample and the higher variability in patients without diabetes
than in those with diabetes. Unlike other studies, we
measured absolute skeletal muscle oxygenation during
dialysis non-invasively in patients at rest. Predialysis tissue
oxygen content HbO2 and CtO2 values were nevertheless
lower in patients with diabetes than in healthy subjects, and
dialysis for 1 hour was sufficient to annul the difference.
Previous data obtained with NIRS technology already docu-
ment higher Hb desaturation in patients with peripheral
vascular disease and diabetes during exercise [30]. In theory,
the reduced baseline skeletal muscle oxygenation (HbO2, StO2
and CtO2) we detected in patients with diabetes at rest could
be related to the microangiopathy typical of diabetes [31].
The reduced oxygenated Hb concentration shown in both
groups of patients could reflect the lower arteriolar and
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Table 4
Variables measured during hemodialysis in healthy subjects and in patients with and without diabetes
Patients without diabetes (n = 10) Patients with diabetes (n = 10)
Healthy subjects 
Variable (n = 22) T0 T1 T2 T3 T0 T1 T2 T3
Body weight  76.35 ±  73.57a ± 71.82c ±  69.62 ±  68.21 ±  92.21a ± 90.82c ±  89.87 ±  88.34 ± 
(kg) 18.34 18.96 17.80 18.76 19.51 21.05 25.13 21.01 22.98
Mean arterial  93.5 ±  95.2 ±  96.2 ±  97.2 ±  98.6 ±  99.1 ±  98.4 ±  101.3 ± 
pressure (mmHg) – 11.1 9.2 7.2 10.9 18.5 11.0 13.4 11.6
[HbT] (μmol/l) 54.18 ±  44.31a ±  58.24 ±  60.43 ±  62.71 ±  44.17a ± 60.32  ± 63.82b ± 73.83  ± 
19.59 19.71 18.67 17.52 18.32 18.61 21.10 24.32 35.40
[HHb] (μmol/l) 20.44 ±  22.69a ±  31.37 ±  32.83 ±  35.92 ±  21.86a ±  30.34 ±  32.75 ±  35.84 ± 
9.85 16.10 17.82 18.43 19.23 10.34 11.32 11.23 14.07
[HbO2] (μmol/l) 33.74e ±  21.62 ±  26.87 ±  27.60 ±  26.79 ±  22.31a ±  29.98 ±  31.07 ±  37.99 ± 
14.17 11.67 11.34 10.43 12.32 11.86 13.45 14.54 18.54
CtO2 (ml O2/ 0.29e ±  0.18 ±  0.23 ±  0.20 ±  0.21 ±  0.19a ± 0.24  ± 0.26b ± 0.32  ± 
100 ml) 0.12 0.13 0.08 0.14 0.11 0.09 0.10 0.09 0.11
Microvascular 0.11e ± 0.161a ± 0.061c ±  0.010 ±  0.006 ±  0.221a ±  0.045 ±  0.019 ±  0.013 ± 
compliance 0.12 0.110 0.041 0.010 0.001 0.140 0.051 0.015 0.010
(ml/mmHg/100 ml)
StO2 (%) 62.3 ±  51.5 ±  50.3 ±  49.1 ±  46.1 ±  49.1 ±  47.9 ±  48.7 ±  50.3 ± 
7.3 21.4 19.9 22.9 21.3 16.6 13.4 12.8 12.3
mHF (μmol/min/ – 1.81 ±  1.74 ±  2.52 ±  1.64 ±  1.76c ±  2.10 ±  3.15 ±  3.11 ± 
100 ml) 1.21 0.98 1.61 0.89 0.82 0.74 1.01 1.52
mBF (ml/min/ 4.01 ±  3.12 ±  3.121 ±  4.33 ±  2.83 ±  3.02d ±  3.76 ±  5.42 ±  5.03 ± 
100 ml) 1.98 2.12 1.55 2.75 1.54 1.78 1.32 1.73 2.41
mVO2 (ml/min/ 0.23 ±  0.34 ±  0.35 ±  0.42 ±  0.36 ±  0.29c ± 0.41d ±  0.72 ±  0.58 ± 
100 ml) 0.13 0.27 0.15 0.22 0.12 0.15 0.13 0.21 0.20
[HbT], total haemoglobin concentration; [HHb], deoxygenated haemoglobin concentration; [HbO2], oxygenated haemoglobin concentration; CtO2,
tissue oxygen content; StO2, tissue oxygen saturation; mHF, muscular haemoglobin flow; mBF, muscular blood flow; mVO2, muscle oxygen
consumption. Wilcoxon test: aP <0.05 vs. beginning of the second hour (T1), beginning of the third hour (T2), beginning of the fourth hour (T3);
bP <0.05 vs. T3; cP <0.05 vs. T2, T3; dP <0.05 vs. T2. Mann–Whitney U test: eP <0.05 vs. predialysis (T0) of patients with diabetes.capillary vascular compared with the venular bed. These micro-
vascular changes reverse during haemodialysis (Table 4).
Even though StO2 predialysis values were lower in patients
with diabetes than in healthy controls, haemodialysis left StO2
unchanged in both groups of patients studied. The absence of
changes in StO2 despite marked changes in tissue [HbT],
[HHb] and [HbO2] – reflecting changes in the vascular bed,
blood flow and mVO2 – confirms that StO2 (percentage tissue
oxygenation) is not merely a variable indicating the balance
between blood flow and oxygen extraction. StO2 depends
critically on the tissue vascular bed, whose volumes vary
substantially under healthy and pathological conditions[32].
Our NIRS findings also extend current knowledge on the in
vivo dialysis-induced changes in the skeletal muscle blood
flow. Ample research on systemic haemodynamics during
haemodialysis already shows, even in haemodynamically
stable subjects, a reduction in cardiac output and oxygen
supply, and indirectly an increase in systemic vascular resis-
tance [14]. These systemic changes led the investigators to
conclude that haemodialysis induces peripheral hypoper-
fusion [33].
Although we cannot compare our findings in patients with
diabetes and studies investigating other groups of patients,
the increased calf blood flow that NIRS documented in our
patients without diabetes seemingly contrast with micro-
neurographic data on the increased sympathetic activity [34].
A possible reason for this discrepancy is that dialysis
increases the [HHb] and [HbO2] variables, reflecting
changes in the numbers of capillaries, arteriovenous shunts,
postcapillary venules and, to a lesser extent, the arterioles
[35]. These vascular bed changes might in theory be
accompanied by increased neuronal sympathetic activity that
could leave overall local tissue blood flow unchanged.
Microvascular bed
A finding that extends current knowledge on the in vivo
effects of haemodialysis was that the volume and distribution
of the microvascular bed increased in both groups of dialyzed
patients. Our data corrected for vascular Hb changes
(Table 2) exclude the possibility that Hb concentrations
increase because dialysis removes excess fluid within
vessels, and suggest that dialysis removes body fluids
outside the vessels, thus reducing interstitial oedema [36],
and at the same time reduces external compression on the
microcirculation. Vasodilation could also arise from dialysis-
induced inflammation through complement factor activation
and vascular endothelial production of cytokines and
prostacyclin [37].
Another reason for vasodilation is that many of our subjects
were taking vasoactive drugs. Calcium antagonists, angio-
tensin-converting enzyme inhibitors, and α-antagonists might
therefore have helped to amplify the response to dialysis-
induced fluid removal, especially given that patients taking
these agents were mostly diabetic individuals. Even though
we excluded patients who had a history of autonomic nervous
system dysfunction or experienced hypotensive episodes
during dialysis, we cannot exclude the possibility that the
abnormal vasodilation especially in patients with diabetes
depended on autonomic dysregulation. Neither autonomic
dysfunction nor medications nevertheless brought about a
reduction in arterial pressures that could have distinguished
between the two study groups.
Microvascular compliance
The mechanism through which haemodialysis reduced
microvascular compliance in our patients remains unclear. A
possible explanation is that it depends on microvascular
dilation, as we suggested in an earlier paper [10]. This
hypothesis agrees with the [HHb] increase we observed in
the present study presumably reflecting venous dilation
strong enough to reduce compliance. The role of dialysis
could be to reduce external compression on the micro-
vascular bed, thus allowing the bed to expand.
Muscle oxygen consumption
In our study we found no differences in mVO2 before dialysis
either between the two groups of patients or between the
patients and healthy controls. The reduced number of muscle
fibres in patients with chronic renal failure [1] presumably
therefore has no effect on oxygen consumption in skeletal
muscle at rest. The absence of changes in mVO2 agrees with
the unchanged baseline metabolism in patients undergoing
chronic dialysis[32,38].
Oxygen supply/consumption relationship
Even though haemodialysis increased tissue [HHb] and
reduced microvascular compliance in both groups of patients
studied, only in those patients with diabetes did dialysis lead
to increased blood flow, HbO2, CtO2 and mVO2. The
increased blood flow was presumably due to the augmented
arteriolar and capillary bed. Because we studied patients at
rest, the increased oxygen availability was presumably not the
consequence but the cause of the increased muscle-tissue
metabolic rate.
Our NIRS findings on the tissue effects induced by
haemodialysis in patients with diabetes also provide useful
information on the relationship between oxygen consumption
and supply. An interesting finding was that even though dialysis
left StO2 statistically unchanged, the increased cell metabolism
was correlated to the increase of blood supply. In our study, we
observed no changes in oxygen supply other than those related
to the dialytic therapy itself – showing that, in the skeletal
muscle of diabetic patients with chronic renal failure at rest,
dialysis reverses the mVO2 limited by blood flow supply. Why
we found a relationship between blood flow and oxygen
consumption only in diabetic subjects remains to be clarified.
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patients without diabetes, the correlation between, on one
hand, the reduced microvascular compliance and, on the
other hand, the deoxygenated Hb tissue concentration and
the increased tissue oxygen consumption seems to confirm
the role of fluid removal during dialysis [39] as a factor
facilitating cell metabolism.
Limitations
Our study has several limitations. First, none of our patients
underwent specific testing to evaluate autonomic system
function. We nevertheless considered it sufficient for the
purposes of this study to exclude subjects who had clinical
signs of autonomic dysfunction.
Second, as other researchers have underlined, subcutaneous
fat interferes with NIRS signals [19]. Although most of the
diabetic patients we studied were heavier than the non-
diabetic subjects, the device we used in the previous study
uses a specific algorithm to correct for signal interference
normally caused by adipose tissue. As we previously
observed [40], this algorithm corrects the measured values
for interference from adipose tissue. Even though our patients
with diabetes were generally heavier than the patients without
diabetes and the healthy controls, we found no difference in
skinfold measures. They may nevertheless have had a higher
water content or more fat, or both, within skeletal muscle
[41].
A possible technical limitation is that the changes in the
microvascular bed we describe are indirectly derived from
changes in tissue Hb concentrations detected by NIRS.
Unfortunately, we cannot compare our results with those from
an in vivo reference technique measuring tissue Hb because
no such standard exists.
Finally, another possible limitation of the study is that the
small patient numbers might have prevented us from
detecting eventual differences (β error). Our strict enrolment
criteria nevertheless prevented us from enrolling a larger
number of patients during the 2-month enrolment period.
Conclusions
Our NIRS findings suggest that haemodialysis in subjects at
rest brings about major changes in skeletal muscle oxygena-
tion and blood flow, microvascular compliance and tissue
metabolic rate. These changes differ in patients without and
with diabetes. In both groups of patients, haemodialysis
induces changes in tissue Hb concentrations and micro-
vascular compliance. Conversely, in those patients with
diabetes, haemodialysis also alters tissue blood flow (mHF
and mBF), tissue oxygenation (CtO2, [HbO2]) and the
metabolic rate (mVO2).
Competing interests
The authors declare that they have no competing interests.
Acknowledgement
This article is part of Critical Care Volume 13 Supplement 5: Tissue
oxygenation (StO2) in healthy volunteers and critically-ill patients. The
full contents of the supplement are available online at http://ccforum.
com/supplements/13/S5. Publication of the supplement has been sup-
ported with funding from Hutchinson Technology Inc.
References
1. Kemp GJ, Crowe AV, Anijeet HK, Gong QY, Bimson WE, Frostick
SP, Bone JM, Bell GM, Roberts JN: Abnormal mitochondrial
function and muscle wasting, but normal contractile effi-
ciency, in haemodialysed patients studied non-invasively in
vivo. Nephrol Dial Transplant 2004, 19:1520-1527.
2. Kouidi E, Albani M, Natsis K, Megalopoulos A, Gigis P, Guiba-
Tziampiri O, Tourkantonis A, Deligiannis A: The effects of exer-
cise training on muscle atrophy in haemodialysis patients.
Nephrol Dial Transplant 1998, 13:685-699.
3. Brodin E, Ljungman S, Hedberg M, Sunnerhagen KS: Physical
activity, muscle performance and quality of life in patients
treated with chronic peritoneal dialysis. Scand J Urol Nephrol
2001, 35:71-78.
4. Sietsema KE, Amato A, Adler SG, Brass EP: Exercise capacity
as a predictor of survival among ambulatory patients with
ESRD. Kidney Int 2004, 65:719-724.
5. Johansen KL: Physical functioning and exercise capacity in
patients on dyalisis. Adv Ren Replace Ther 1999, 6:141-148.
6. Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar ME, London
GM:  Postischemic vasodilation, endothelial activation and
cardiovascular remodelling in end-stage renal disease. Kidney
Int 2000, 57:1091-1099.
7. London GM, Pannier B, Agharazii M, Guerin AP, Verbke FH, Mar-
chais SJ: Forearm reactive hyperemia and mortalità in end-
stage renal disease. Kidney Int 2004, 65:700-704.
8. Passauer J, Pistrosch F, Büssemaker E, Lässig G, Herbrig K,
Gross P: Reduced agonist-induced endothelium-dependent
vasodilation in uremia is attributable to an impairment of vas-
cular nitric oxide. J Am Soc Nephrol 2005, 16:959-965.
9. Marrades RM, Roca J, Campistol JM, Diaz O, Barberá JA, Torre-
grosa JV, Masclans JR, Cobos A, Rodríguez-Roisin R, Wagner
PD: Effects of erythropoietin on muscle O2 transport during
exercise in patients with chronic renal failure. J Clin Invest
1996, 97:2092-2100.
10. De Blasi RA, Palmisani S, Alampi D, Mercieri M, Romano R, Collini
S, Pinto G: Microvascular dysfunction and skeletal muscle
oxygenation assessed by phase-modulation near-infrared
spectroscopy in patients with septic shock. Intensive Care
Med 2005, 31:1661-1668.
11. Schalkwijk CG, Stehouwer CD: Vascular complications in dia-
betes mellitus: the role of endothelial dysfunction. Clin Sci
(Lond) 2005, 109:143-159.
12. Morbach S, Quante C, Ochs HR, Gaschler F, Pallast J-M, Knevels
U: Increased risk of lower-extremity amputation among Cau-
casian diabetic patients on dialysis. Diabetes Care 2001, 24:
1689-1670.
13. McGrath NM, Curran BA: Recent commencement of dialysis is
a risk factor for lower-extremity amputation in a high-risk dia-
betic population. Diabetes Care 2000, 23:432-433.
14. Bos WJW, Buin Sjoerd, van Older RW, Keur I, Wesseling KH,
Westerhof N, Krediet RT, Aritsz LA: Cardiac and hemodynamic
effects of hemodialysis and ultrafiltration. Am J Kidney Dis
2000, 35:819-826.
15. Converse RL, Jacobsen TN, Fouad-Tarazi F, Obregon TM, Toto
RD, Victor RG: Paradoxical withdrawal of reflex vasoconstric-
tion as a cause of hemodialysis-induced hypotension. J Clin
Invest 1992, 90:1657-1665.
16. van der Sande FM, Kooman JP, van Kuijk WHM, Leunissen KML:
Management of hypotension in dialysis patients: role of
dialysate temperature control. Saudi J Kidney Dis Transplant
2001, 12:328-386.
17. Rovati L, Bandera A, Donini M, Salvatori G: Design and perfor-
mance of a wide-bandwidth and sensitive instrument for
near-infrared spectroscopic measurements on human tissue.
Rev Sci Instrum 2004, 75:5315-5325.
18. Matcher S, Cope M, Delpy D: Use of the water absorption
spectrum to quantify tissue chromophore concentration
changes in near infrared spectroscopy. Phys Med Biol 1993,
38:177-196.
Available online http://ccforum.com/content/13/S5/S9
Page 9 of 10
(page number not for citation purposes)19. Van Beekvelt M, Borghuis M, Van Engelen B, Wevers R, Collier
W: Adipose tissue thickness affects in vivo quantitative near-
IR spectroscopy in human skeletal muscle. Clin Sci (Lond)
2001, 101:21-28.
20. Martelli F, Del Bianco S, Zaccanti G: Effect of the refractive
index mismatch on light propagation through diffusive
layered media. Phys Rev E Stat Nonlin Soft Matter Phys 2004,
70:011907.
21. Simpson CR, Kohl M, Essenpreis M, Cope M: Near-infrared
optical properties of ex vivo human skin and subcutaneous
tissues measured using the Monte Carlo inversion technique.
Phys Med Biol 1998, 43:2465-2478.
22. Castaneda-Sceppa C, Sarnak MJ, Wang X, Greene T, Madero M,
Kusek JW, Beck G, Kopple JD, Levey AS, Menon V: Role of
adipose tissue in determining muscle mass in patients with
chronic kidney disease. J Renal Nutr 2007, 17:314-322.
23. Klitzman B, Duling BR: Microvascular hematocrit and red cell
flow in resting and contracting striated muscle. Am J Physiol
1979, 237:H481-H490.
24. De Blasi RA, Ferrari M, Natali A, Conti G, Mega A, Gasparetto A:
Noninvasive measurement of forearm blood flow and oxygen
consumption by near-infrared spectroscopy. J Appl Physiol
1994, 76:1388-1393.
25. Wolf U, Wolf M, Choi JH, Levi M, Choudhury D, Hull S, Coussirat
D, Paunescu LA, Safonova LP, Michalos A, Mantulin WW,Gratton
E: Localized irregularities in haemoglobin flow and oxygena-
tion in calf muscle in patients with peripheral vascular
disease detected with near-infrared spectrophotometry. J
Vasc Surg 2003, 37:1017-1026.
26. Weiss T, Windthorst C, Weiss C, Kreuzer J, Bomber J, Kübler W:
Acute effects of haemodialysis on cutaneous microcirculation
in patients with peripheral arterial occlusive disease. Nephrol
Dial Transplant 1998, 13:2317-2321.
27. Hinchliffe RJ, Kirk B, Bhattacharjee D, Roe S, Jeffcoate W, Game
F:  The effect of haemodialysis on transcutaneous oxygen
tension in patients with diabetes – a pilot study. Nephrol Dial
Transplant 2006, 21:1981-1983.
28. Abu-Hamdan DK, Desai SG, Mahajan SK, Muller BF, Briggs WA,
Lynne-Davies P, McDonald FD: Hypoxemia during haemodialy-
sis using acetate versus bicarbonate dialysate. Am J Nephrol
1984, 4:248-253.
29. Pitcher WD, Diamond SM, Henrich WL: Pulmonary gas
exchange during dialysis in patients with obstructive lung
disease. Chest 1989, 96:1136-1141.
30. Hamaoka T, McCully KK, Quaresima V, Yamamoto K, Chance B:
Near-infrared spectroscopy/imaging for monitoring muscle
oxygenation and oxidative metabolism in healthy and dis-
eased humans. J Biomed Opt 2007, 12:62105.
31. Rooke TW, Osmundson PJ: The influence of age, sex, smoking,
and diabetes on lower limb transcutaneous oxygen tension in
patients with arterial occlusive disease. Arch Intern Med 1990,
150:129-132.
32. Sala E, Noyszewski EA, Campistol JM, Marrades RM, Dreha S,
Torregrossa JV, Beers JS, Wagner PD, Roca J: Impaired muscle
oxygen transfer in patients with chronic renal failure. Am J
Physiol Regul Integr Comp Physiol 2001, 280:R1240-R1248.
33. Schneditz D, Zaluska WT, Morris AT, Levin NW: Effects of ultra-
filtration on peripheral urea sequestration in haemodialysis
patients. Nephrol Dial Transplant 2001, 16:994-998.
34. Hansen J, Victor RG: Direct measurement of sympathetic
activity: new insights into disordered blood pressure regula-
tion an chronic renal failure. Curr Opin Nephrol Hypertens
1994, 3:636-643.
35. Mancini DM, Bolinger L, Li H Kendrick, Chance B, Wilson JR: Val-
idation of near infrared spectroscopy in humans. J Appl
Physiol 1994, 77:2740-2747.
36. Movilli E, Cancarini GC, Cassamali S, Camerini C, Brunori G,
Maffei C, Maiorca R: Inter dialytic variations in blood volume
and total body water in uraemic patients treated by dialysis.
Nephrol Dial Transplant 2004, 19:185-189.
37. Jofré R, Rodriguez-Benitez P, López-Gómez JM, Pérez-Garcia R:
Inflammatory syndrome in patients on haemodialysis. J Am
Soc Nephrol 2006, 17:274-280.
38. Kamimura MA, Draibe SA, Avesani CM, Canziani MEF, Colugnani
FAB, Cuppari L: Resting energy expenditure and its determi-
nants in haemodialysis patients. Eur J Clin Nutr 2007, 61:362-
367.
39. Minutolo R, De Nicola L, Bellizzi V, Iodice C, Rubino R, Aucella F,
Stallone C, Nappi F, Avella F, Maione E, Conte G, Di Iorio BR:
Intra- and post-dialytic changes of haemoglobin concentra-
tions in non-anaemic haemodialysis patients. Nephrol Dial
Transplant 2003, 18:2606-2612.
40. De Blasi RA, Palmisani S, Boezi M, Arcioni R, Collini S, Troisi F,
Pinto G: Effects of remifentanil-based general anaesthesia
with propofol or sevoflurane on muscle microcirculation as
assessed by near-infrared spectroscopy. Br J Anesth 2008,
101:171-177.
41. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcel-
loni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L:
Intramyocellular triglyceride content is a determinant of in
vivo insulin resistance in humans: a 1H–13C nuclear magnetic
resonance spectroscopy assessment in offspring of type 2
diabetic parents. Diabetes 1999, 48:1600-1606.
Critical Care    Vol 13 Suppl 5 De Blasi et al.
Page 10 of 10
(page number not for citation purposes)